174 related articles for article (PubMed ID: 32268247)
1. Biallelic and monoallelic deletion of the RB1 promoter in six isogenic clonal H9 hESC lines.
Döpper H; Horstmann M; Menges J; Bozet M; Kanber D; Steenpass L
Stem Cell Res; 2020 May; 45():101779. PubMed ID: 32268247
[TBL] [Abstract][Full Text] [Related]
2. Generation of two H1 hESC sublines carrying deletions of RB1 exon 1/promoter in heterozygous or compound heterozygous state.
Menges J; Cremanns M; Steenpass L
Stem Cell Res; 2019 Aug; 39():101517. PubMed ID: 31404748
[TBL] [Abstract][Full Text] [Related]
3. Characterization of human-induced pluripotent stem cells carrying homozygous RB1 gene deletion.
Deng X; Iwagawa T; Fukushima M; Watanabe S
Genes Cells; 2020 Jul; 25(7):510-517. PubMed ID: 32277725
[TBL] [Abstract][Full Text] [Related]
4. Role of RB1 in human embryonic stem cell-derived retinal organoids.
Zheng C; Schneider JW; Hsieh J
Dev Biol; 2020 Jun; 462(2):197-207. PubMed ID: 32197890
[TBL] [Abstract][Full Text] [Related]
5. Modeling Developmental and Tumorigenic Aspects of Trilateral Retinoblastoma via Human Embryonic Stem Cells.
Avior Y; Lezmi E; Yanuka D; Benvenisty N
Stem Cell Reports; 2017 May; 8(5):1354-1365. PubMed ID: 28392220
[TBL] [Abstract][Full Text] [Related]
6. Spectrum of mutations in the
Kiet NC; Khuong LT; Minh DD; ; Quan NHM; Xinh PT; Trang NNC; Luan NT; Khai NM; Vu HA
Mol Vis; 2019; 25():215-221. PubMed ID: 30996590
[TBL] [Abstract][Full Text] [Related]
7. Generation of two H1 hESC sublines carrying a heterozygous and homozygous knock-out of RB1.
Steenpass L
Stem Cell Res; 2017 Dec; 25():270-273. PubMed ID: 29246572
[TBL] [Abstract][Full Text] [Related]
8. "Monoallelic germline methylation and sequence variant in the promoter of the RB1 gene: a possible constitutive epimutation in hereditary retinoblastoma".
Quiñonez-Silva G; Dávalos-Salas M; Recillas-Targa F; Ostrosky-Wegman P; Aranda DA; Benítez-Bribiesca L
Clin Epigenetics; 2016; 8():1. PubMed ID: 26753011
[TBL] [Abstract][Full Text] [Related]
9. Next-Generation Sequencing of Retinoblastoma Identifies Pathogenic Alterations beyond RB1 Inactivation That Correlate with Aggressive Histopathologic Features.
Afshar AR; Pekmezci M; Bloomer MM; Cadenas NJ; Stevers M; Banerjee A; Roy R; Olshen AB; Van Ziffle J; Onodera C; Devine WP; Grenert JP; Bastian BC; Solomon DA; Damato BE
Ophthalmology; 2020 Jun; 127(6):804-813. PubMed ID: 32139107
[TBL] [Abstract][Full Text] [Related]
10. Generation and characterization of three CRISPR/Cas9 edited RB1 null hiPSC lines for retinoblastoma disease modelling.
Agrawal T; Maddileti S; Mariappan I
Stem Cell Res; 2024 Apr; 76():103373. PubMed ID: 38452707
[TBL] [Abstract][Full Text] [Related]
11. Detection and reporting of RB1 promoter hypermethylation in diagnostic screening.
Price EA; Kolkiewicz K; Patel R; Hashim S; Karaa E; Scheimberg I; Sagoo MS; Reddy MA; Onadim Z
Ophthalmic Genet; 2018 Aug; 39(4):526-531. PubMed ID: 29851531
[TBL] [Abstract][Full Text] [Related]
12. Investigation of the methylation changes in the promoter region of RB1 gene in retinoblastoma: Unraveling the epigenetic puzzle in retinoblastoma.
Erdoğan ÖŞ; Ödemiş DA; Kayım ZY; Gürbüz O; Tunçer ŞB; Kılıç S; Çelik B; Tuncer S; Bay SB; Kebudi R; Yazıcı H
Pathol Res Pract; 2024 Jan; 253():154939. PubMed ID: 38006838
[TBL] [Abstract][Full Text] [Related]
13. Generation of an induced pluripotent stem cell line (LVPEIi002-A) with heterozygous RB1 mutation using peri-orbital fat derived mesenchymal cells of a patient with inherited retinoblastoma.
Agrawal T; Maddileti S; Verma A; Kaliki S; Mariappan I
Stem Cell Res; 2024 Apr; 76():103329. PubMed ID: 38335663
[TBL] [Abstract][Full Text] [Related]
14. Generation of heterozygous and homozygous hESC H9 sublines carrying inactivating mutations in RB1.
Schipper L; Kanber D; Steenpass L
Stem Cell Res; 2018 Dec; 33():41-45. PubMed ID: 30312872
[TBL] [Abstract][Full Text] [Related]
15. Spectrum of germline
Rojanaporn D; Boontawon T; Chareonsirisuthigul T; Thanapanpanich O; Attaseth T; Saengwimol D; Anurathapan U; Sujirakul T; Kaewkhaw R; Hongeng S
Mol Vis; 2018; 24():778-788. PubMed ID: 30636860
[TBL] [Abstract][Full Text] [Related]
16. Molecular alterations in retinoblastoma beyond RB1.
Mendonça V; Evangelista AC; P Matta B; M Moreira MÂ; Faria P; Lucena E; Seuánez HN
Exp Eye Res; 2021 Oct; 211():108753. PubMed ID: 34478740
[TBL] [Abstract][Full Text] [Related]
17. Lack of correlation between age at diagnosis and RB1 mutations for unilateral retinoblastoma: the importance of genetic testing.
Berry JL; Lewis L; Zolfaghari E; Green S; Le BHA; Lee TC; Murphree AL; Kim JW; Jubran R
Ophthalmic Genet; 2018 Jun; 39(3):407-409. PubMed ID: 29286867
[No Abstract] [Full Text] [Related]
18. Dissecting the Transcriptional and Chromatin Accessibility Heterogeneity of Proliferating Cone Precursors in Human Retinoblastoma Tumors by Single Cell Sequencing-Opening Pathways to New Therapeutic Strategies?
Collin J; Queen R; Zerti D; Steel DH; Bowen C; Parulekar M; Lako M
Invest Ophthalmol Vis Sci; 2021 May; 62(6):18. PubMed ID: 34003213
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological induction of translational readthrough of nonsense mutations in the retinoblastoma (RB1) gene.
Palomar-Siles M; Yurevych V; Bykov VJN; Wiman KG
PLoS One; 2023; 18(11):e0292468. PubMed ID: 37917619
[TBL] [Abstract][Full Text] [Related]
20. Investigation of new candidate genes in retinoblastoma using the TruSight One "clinical exome" gene panel.
Akdeniz D; Tuncer SB; Kebudi R; Celik B; Kuru G; Kilic S; Sukruoglu Erdogan O; Avsar M; Buyukkapu Bay S; Tuncer S; Yazici H
Mol Genet Genomic Med; 2019 Aug; 7(8):e785. PubMed ID: 31207142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
